Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 169-174

  Kheadr, E ^a,b   Dabour, N ^a,b   Le Lay, C ^a   Lacroix, C ^c   Fliss, I ^a,d  

^a LAVAL UNIVERSITY   (Canada)

^b Alexandria University   (Egypt)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLOXACILLIN; ERYTHROMYCIN; HYDROGEN PEROXIDE; KANAMYCIN; NEOMYCIN; NISIN; NISIN A; PAROMOMYCIN; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; DIARRHEA; GASTROINTESTINAL TRACT; INTESTINE INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PH; PRIORITY JOURNAL;

ACIDS; AMPICILLIN; ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM; CHLORAMPHENICOL; CLOXACILLIN; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; NISIN; PENICILLINS; SPECIES SPECIFICITY; TETRACYCLINES; VANCOMYCIN;

EID: 33846030178     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00261-06     Document Type: Article

References (32)

1. Alesting, K., H. Carlberg, C. E. Nord, and B. Trollfors. 1983. Effect of cefoperazone on faecal flora. J. Antimicrob. Agents Chemother. 12:163-167.
2. Appelbaum, P. C., and S. A. Chatterton. 1978. Susceptibility of anaerobic bacteria to ten antimicrobial agents. J. Antimicrob. Agents Chemother. 14:371-376.
3. Beerens, H. 1990. An elective and selective isolation media for Bifidobacterium ssp. Lett. Appl. Microbiol. 11:155-158.
4. Black, F., K. Einarsson, A. Lidbeck, K. Orrhage, and C. E. Nord. 1991. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scand. J. Infect. Dis. 23:247-254.
5. Cabiscol, E., J. Tamarit, and J. Ros. 2000. Oxidative stress in bacteria and protein damage by reactive oxygen species. Int. Microbiol. 3:3-8.
6. Charteris, W. P., P. M. Kelly, L. Morelli, and J. K. Collins. 1998. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84:759-768.
7. Charteris, W. P., P. M. Kelly, L. Morelli, and J. K. Collins. 2000. Effect of conjugated oxgall salts on antibiotic susceptibility of oxgall salt-tolerant Lactobacillus and Bifidobacterium isolates. J. Food Prot. 63:1369-1376.
8. Danielsen, M., and A. Wind. 2003. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int. J. Food Microbiol. 82:1-11.
9. Dave, R. I., and N. P. Shah. 1997. Viability of yoghurt and probiotic bacteria in yoghurts made from commercial starter culture. Int. Dairy J. 7:31-41.
10. Davis, B. D. 1987. Mechanism of bactericidal action of aminoglycosides. Microbiol. Rev. 51:341-350.
11. Duffy, L. C., M. A. Zielezny, M. Riepenhoff-Talty, D. Dryia, S. Sayahtaheri-Altaie, E. Griffiths, D. Ruffin, H. Barret, J. Rossman, and P. L. Ogra. 1993. Effectiveness of Bifidobacterium bifidum in experimentally induced MRV infection: dietary implications in formulas for newborns. Endocrine Regulations 27:223-229.
12. Elmer, G. W., C. M. Surawicz, and L. V. McFarland. 1996. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870-876.
13. Gagnon, M., E. E. Kheadr, G. Le Blay, and I. Fliss. 2004. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. Int. J. Food Microbiol. 92:69-78.
14. Giamarellou, H. 1986. Aminoglycosides plus β-lactams against Gram-negative organisms: evaluation of in vitro synergy and chemical interactions. Am. J. Med. 80(Suppl. 6B): 126-137.
15. Halliwell, B., and J. M. Gutteridge. 1985. Free radicals in biology and medicine, p. 20-64. Clarendon Press, Oxford, United Kingdom.
16. Handwerger, S., M. J. Pucci, K. J. Volk, J. P. Liu, and M. S. Lee. 1994. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J. Bacteriol. 176:260-264.
17. Hughes, D. B., and D. G. Hoover. 1991. Bifidobacteria: their potential for use in American dairy products. Food Technol. 45:74-79.
18. Ishibashi, N., T. Yaeshima, and H. Hayasawa. 1997. Bifidobacteria: their significance in human intestinal health. Malays. J. Nutr. 3:149-156.
19. Kheadr, E. E., N. Bernoussi, C. Lacroix, and I. Fliss. 2004. Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. Int. Dairy J. 14:1041-1053.
20. Kot, E., and A. Bezkorovainy. 1998. Effect of hydrogen peroxide on physiology of Bifidobacterium thermophilum. J. Agric. Food Chem. 46:2921-2925.
21. Kot, E., Y. Murad, and A. Bezkorovainy. 2001. The effect of nisin on the physiology of Bifidobacterium thermophilum. J. Food Prot. 4:1206-1210.
22. Lim, K. S., C. S. Huh, and Y. J. Back. 1993. Antimicrobial susceptibility of bifidobacteria. J. Dairy Sci. 76:2168-2174.
23. Modler, H. W., R. C. Mckellar, and M. Yaguchi. 1990. Bifidobacteria and bifidogenic factors. Can. Inst. Food Sci. Technol. 23:29-41.
24. Mota-Meira, M., G. LaPointe, C. Lacroix, and M. Lavoie. 2000. MICs of mutacin BNy266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother. 44:24-29.
25. National Committee for Clinical Laboratory Standards. 1991. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. NCCLS, Villanova, PA.
26. Noriega, L., M. Gueimonde, B. Sanchez, A. Margolles, and C. de los Reyes-Gavilan. 2004. Effect of the adaptation to high oxgall salts concentrations on glycosidic activity, survival at low pH and cross-resistance to oxgall salts in Bifidobacterium. Int. J. Food Microbiol. 94:79-86.
27. Pochart, P., P. Marteau, B. Y. Goderal, P. I. Bourlioux, and J. C. Rambaud. 1992. Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am. J. Clin. Nutr. 55:78-80.
28. Ruoff, K. L., D. R. Kuritzkes, J. S. Wolfson, and M. J. Ferraro. 1988. Vancomycin-resistant gram-positive bacteria isolated from human sources. J. Clin. Microbiol. 26:2064-2068.
29. Swenson, J. M., R. R. Facklamand, and C. Thornsberry. 1990. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob. Agents Chemother. 34:543-549.
30. Tissier, H. 1900. Recherche sur la flore intestinale des nousons (état normale et pathologique). Ph.D. thesis. University of Paris School of Medicine, Paris, France.
31. Yazid, A. M., A. M. Ali, M. Shuhaimi, V. Kalaivaani, M. Y. Rokiah, and A. Reezal. 2000. Antimicrobial susceptibility of bifidobacteria. Lett. Appl. Microbiol. 31:57-62.
32. Yoshioka, H., K. Fujita, H. Sakata, K. Murono, and K. Iseki. 1991. Development of the normal intestinal flora and its clinical significance in infants and children. Bifidobacteria Microflora 10:11-17.